Endoscopic Retrograde Cholangiopancreatography (ERCP) Market Share

Statistics for the 2023 & 2024 Endoscopic Retrograde Cholangiopancreatography (ERCP) market share, created by Mordor Intelligence™ Industry Reports. Endoscopic Retrograde Cholangiopancreatography (ERCP) share report includes a market forecast to 2029 and historical overview. Get a sample of this industry share analysis as a free report PDF download.

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Market Share of Endoscopic Retrograde Cholangiopancreatography (ERCP) Industry

The market is highly competitive and consists of several global players. As the market is progressing, the firms are trying to achieve clear differentiation in endoscopic systems based on their application. Due to the requirements for high-quality imaging and operative capabilities, various customer groups are shifting toward optimized visualization systems that integrate various ERCP devices. Some of the key players include Olympus Corporation, CONMED Corporation, Fujifilm Holdings Corporation, Boston Scientific Corporation, Johnson & Johnson, Medtronic PLC, Cook Medical, and DCC Healthcare (Medi-Globe GmbH).

Endoscopic Retrograde Cholangiopancreatography (ERCP) Market Leaders

  1. CONMED Corporation

  2. STERIS PLC

  3. Cook Medical

  4. Fujifilm Holdings Corporation

  5. Olympus Corporation

*Disclaimer: Major Players sorted in no particular order

Endoscopic Retrograde Cholangiopancreatography (ERCP) Market Concentration

Endoscopic Retrograde Cholangiopancreatography (ERCP) Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)